Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,717Revenue (TTM) $M228Net Margin (%)42.3Altman Z-Score10.2
Enterprise Value $M1,633EPS (TTM) $1.8Operating Margin %28.3Piotroski F-Score7
P/E(ttm)18.7Beneish M-Score-2.0Pre-tax Margin (%)27.0Higher ROA y-yY
Price/Book8.210-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsN
Price/Sales7.75-y EBITDA Growth Rate %--Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow21.5y-y EBITDA Growth Rate %177ROA % (ttm)36.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)57.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M50.3ROIC % (ttm)101Gross Margin Increase y-yN

Gurus Latest Trades with SUPN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

SUPN is held by these investors:



SUPN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bhatt Padmanabh P.Sr. VP of IP, CSO 2017-04-24Sell11,806$32.594.79view
PATRICK GREGORY SVP, CFO 2017-04-24Sell54,000$32.375.5view
PATRICK GREGORY SVP, CFO 2016-09-16Sell2,000$2536.6view
PATRICK GREGORY SVP, CFO 2016-07-14Sell3,395$2255.23view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2016-04-11Sell30,762$16.49107.1view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-12-09Sell14,238$14.9129.19view
BARRETT M JAMESDirector 2015-12-08Sell212,970$14.56134.55view
BARRETT M JAMESDirector 2015-11-25Sell16,179$16.35108.87view
BARRETT M JAMESDirector 2015-11-18Sell93,000$16.61105.6view
BARRETT M JAMESDirector 2015-11-16Sell119,650$16.24110.28view

Press Releases about SUPN :

Quarterly/Annual Reports about SUPN:

News about SUPN:

Articles On GuruFocus.com
Supernus to Host First Quarter 2017 Earnings Conference Call Apr 26 2017 
Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and Adol Apr 05 2017 
Supernus Announces Settlement with Actavis on Trokendi XR® Patent Litigation Mar 07 2017 
Supernus Announces Settlement with Zydus on Trokendi XR® Patent Litigation Mar 06 2017 
Robert Bruce new Buys Feb 16 2015 
Third Quarter Was Robert Bruce's Busiest in 2014 Nov 21 2014 
Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 

More From Other Websites
Top 4 Pharmaceutical Stocks for 2017 May 19 2017
Want to Get in on Biotech? Check Out These 3 Stocks May 16 2017
Edited Transcript of SUPN earnings conference call or presentation 10-May-17 1:00pm GMT May 16 2017
Biotech Movers: Anika Up on Strong Analyst Ratings May 12 2017
Investor Network: Supernus Pharmaceuticals, Inc. to Host Earnings Call May 10 2017
Supernus misses Street 1Q forecasts May 09 2017
Supernus Announces First Quarter 2017 Financial Results May 09 2017
Supernus to Host First Quarter 2017 Earnings Conference Call Apr 26 2017
Harry Boxer’s momentum stocks to watch: 3 biotechs, 1 retailer Apr 19 2017
This Biotech Leader Breaks Out, Defying Sector Odds Apr 18 2017
Supernus Drug Gets Label Expansion for Migraines Apr 06 2017
Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and... Apr 05 2017
3 Highest Growth Stocks in the Market Today Mar 29 2017
Ultragenyxs’ Seizure Drug Fails Study Mar 23 2017
Supernus Pharma Tanks on Settlement of Two Patent Disputes (SUPN) Mar 08 2017
These Pharma Stocks Are Big Losers From Trump's Drug-Pricing Tweet Mar 07 2017
Supernus Announces Settlement with Actavis on Trokendi XR® Patent Litigation Mar 07 2017
Supernus Announces Settlement with Zydus on Trokendi XR® Patent Litigation Mar 06 2017
ETFs with exposure to Supernus Pharmaceuticals, Inc. : March 6, 2017 Mar 06 2017
Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Mar 03 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat